Literature DB >> 22729072

The classification of motor neuron defects in the zebrafish embryo toxicity test (ZFET) as an animal alternative approach to assess developmental neurotoxicity.

Elke Muth-Köhne1, Arne Wichmann, Vera Delov, Martina Fenske.   

Abstract

Rodents are widely used to test the developmental neurotoxicity potential of chemical substances. The regulatory test procedures are elaborate and the requirement of numerous animals is ethically disputable. Therefore, non-animal alternatives are highly desirable, but appropriate test systems that meet regulatory demands are not yet available. Hence, we have developed a new developmental neurotoxicity assay based on specific whole-mount immunostainings of primary and secondary motor neurons (using the monoclonal antibodies znp1 and zn8) in zebrafish embryos. By classifying the motor neuron defects, we evaluated the severity of the neurotoxic damage to individual primary and secondary motor neurons caused by chemical exposure and determined the corresponding effect concentration values (EC₅₀). In a proof-of-principle study, we investigated the effects of three model compounds thiocyclam, cartap and disulfiram, which show some neurotoxicity-indicating effects in vertebrates, and the positive controls ethanol and nicotine and the negative controls 3,4-dichloroaniline (3,4-DCA) and triclosan. As a quantitative measure of the neurotoxic potential of the test compounds, we calculated the ratios of the EC₅₀ values for motor neuron defects and the cumulative malformations, as determined in a zebrafish embryo toxicity test (zFET). Based on this index, disulfiram was classified as the most potent and thiocyclam as the least potent developmental neurotoxin. The index also confirmed the control compounds as positive and negative neurotoxicants. Our findings demonstrate that this index can be used to reliably distinguish between neurotoxic and non-neurotoxic chemicals and provide a sound estimate for the neurodevelopmental hazard potential of a chemical. The demonstrated method can be a feasible approach to reduce the number of animals used in developmental neurotoxicity evaluation procedures.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22729072     DOI: 10.1016/j.ntt.2012.04.006

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  6 in total

1.  Triclosan-induced neuroinflammation develops caspase-independent and TNF-α signaling pathway associated necroptosis in Neuro-2a cells.

Authors:  Parul Katiyar; Somesh Banerjee; Sandip Nathani; Partha Roy
Journal:  Curr Res Toxicol       Date:  2022-05-06

2.  The toxicity of silver nanoparticles to zebrafish embryos increases through sewage treatment processes.

Authors:  Elke Muth-Köhne; Laura Sonnack; Karsten Schlich; Florian Hischen; Werner Baumgartner; Kerstin Hund-Rinke; Christoph Schäfers; Martina Fenske
Journal:  Ecotoxicology       Date:  2013-08-22       Impact factor: 2.823

Review 3.  Zebrafish: An emerging whole-organism screening tool in safety pharmacology.

Authors:  Vandana S Nikam; Deeksha Singh; Rohan Takawale; Minal R Ghante
Journal:  Indian J Pharmacol       Date:  2020 Nov-Dec       Impact factor: 1.200

4.  Use of the zebrafish larvae as a model to study cigarette smoke condensate toxicity.

Authors:  Lee D Ellis; Evelyn C Soo; John C Achenbach; Michael G Morash; Kelly H Soanes
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

5.  Perinatal Exposure to Triclosan Results in Abnormal Brain Development and Behavior in Mice.

Authors:  Dinh Nam Tran; Eui-Man Jung; Yeong-Min Yoo; Jae-Hwan Lee; Eui-Bae Jeung
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

6.  Developmental and Reproductive Outcomes in Male Rats Exposed to Triclosan: Two-Generation Study.

Authors:  Bruno Garcia Montagnini; Simone Forcato; Karine Vandressa Pernoncine; Mariana Cunha Monteiro; Marina Rangel Ferro Pereira; Nathalia Orlandini Costa; Estefânia Gastadello Moreira; Janete Aparecida Anselmo-Franci; Daniela Cristina Ceccatto Gerardin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-13       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.